Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-11

Clinical Trial Update: Effect of Secretin in Functional Dyspepsia and Healthy Subjects [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on secretin for functional dyspepsia and healthy subjects across Phase 1 and Phase 2 have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Secretin (secretin)

Snippet

Sponsor: Mayo Clinic | Conditions: Dyspepsia, Healthy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-06-11